This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/business/581077-denmark-drug-firm-gdp/
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
Domestic company worth more than EU state’s entire GDP | Domestic company worth more than EU state’s entire GDP |
(about 2 hours later) | |
A blockbuster weight-loss drug has sent Danish manufacturer Novo Nordisk’s shares sky-high | |
Danish healthcare company Novo Nordisk saw its shares skyrocket this week, pushing its market value above Denmark’s GDP, according to trading data. | |
The drugmaker’s shares surged as much as 19% on Tuesday, its largest intraday gain on record, following a report that its highly-popular obesity drug Wegovy cuts the risk of heart attacks and strokes. According to the study, people suffering from obesity who have heart issues were 20% less likely to suffer a cardiovascular event when taking Wegovy than those who took a placebo. | The drugmaker’s shares surged as much as 19% on Tuesday, its largest intraday gain on record, following a report that its highly-popular obesity drug Wegovy cuts the risk of heart attacks and strokes. According to the study, people suffering from obesity who have heart issues were 20% less likely to suffer a cardiovascular event when taking Wegovy than those who took a placebo. |
Following the stock price rally, the company’s market capitalization jumped more than $60 billion to around $423 billion, which is more than the size of Denmark’s entire domestic economy. The country’s GDP amounted to $390.68 billion as of the end of 2022. | Following the stock price rally, the company’s market capitalization jumped more than $60 billion to around $423 billion, which is more than the size of Denmark’s entire domestic economy. The country’s GDP amounted to $390.68 billion as of the end of 2022. |
The rally also propelled Novo Nordisk to number two among the EU’s largest companies in terms of value after French luxury products conglomerate LVMH, which is worth $442 billion. | The rally also propelled Novo Nordisk to number two among the EU’s largest companies in terms of value after French luxury products conglomerate LVMH, which is worth $442 billion. |
Novo Nordisk, which originally specialized in diabetes products, has held the title of highest valued company in Denmark since 2008, when it overtook container-shipping giant A.P. Moller-Maersk. It has gained increased investor interest over the past three years after launching weight-loss drugs. The company’s stock has tripled since 2020. | Novo Nordisk, which originally specialized in diabetes products, has held the title of highest valued company in Denmark since 2008, when it overtook container-shipping giant A.P. Moller-Maersk. It has gained increased investor interest over the past three years after launching weight-loss drugs. The company’s stock has tripled since 2020. |
According to Bloomberg calculations, it is now worth more than all the other companies in the Danish benchmark index, the OMXC25, combined. | According to Bloomberg calculations, it is now worth more than all the other companies in the Danish benchmark index, the OMXC25, combined. |
For more stories on economy & finance visit RT's business section | For more stories on economy & finance visit RT's business section |
Previous version
1
Next version